by The women’s health devices market sales was valued at approximately USD 30.86 billion in 2021, and it is expected to witness a revenue of USD 62.34 billion in 2030, with a CAGR of 8.1% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030.
The women’s health devices market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decisions to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1492
A strong growth in the women’s healthcare expenditure has been witnessed across the globe. The growing focus on the women’s healthcare coupled with the increased personal disposable income of the women has fostered the growth of the women’s health devices market across the globe. The rising participation of the women in the workforce especially in the developed nations has significantly contributed towards the growth of the market. Moreover, the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and diabetes among the women population is fueling the growth of the global women’s health devices market.
According to the International Agency for Research on Cancer, the female breast cancer has become the most diagnosed type of cancer by surpassing the lungs cancer. Around 2.3 million new cases of breast cancer were reported in 2020. Around 9.2 million new cases of cancer and 4.4 million cancer deaths in female were reported in 2020. These numbers are boosting the healthcare expenditure in the women’s health devices.
Coverage of the Womens Health Devices Market
| Report Highlights | Details |
| Market Size | US$ 62.3 Billion by 2030 |
| Growth Rate | CAGR of 8.1% from 2021 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Product, Application, Region |
Competitive Intelligence
The report provides an understanding of the market composition and explains the role of established players and regional contributors. It is essential for the market players to make calculative moves and focus on client acquisition and retention. The detailed company profiles will provide the necessary intelligence to the reader. In order to maintain their share, the market players are focusing on strategies such as cross-border expansion, product differentiation and so on.
Some of the prominent players in the global women’s health devices market are listed as below:
- GE Healthcare
- F. Hoffmann-La Roche
- Hologic
- Koninklijke Philips
- Siemens AG
- Prestige Consumer Healthcare, Inc.
- Abbott Laboratories
- Caldera Medical
- MedGyn Products
- Medline Industries
- Carestream Health
North America to Lead Backed by Rising Healthcare Spending by Companies
North America held the largest women’s health devices market share and was worth USD 16+ billion in 2020 and is probable to be measured as the biggest market in the forthcoming years. Hefty healthcare spending for women’s health in the region, united with the reasonably higher demand for technologically innovative gadgets in the region, are a few of the features that are liable for the domination of this region.
Europe generated the second-largest share in 2020 in the market, which is credited to the sturdy female healthcare expenditure in crucial European nations, coupled with the existence of a considerable female populace in Europe.
Asia Pacific region is projected to observe the highest CAGR during the forecast period of 2021-2030. The enhancement in healthcare substructure in Asian countries, increasing incidence of women’s diseases, and the escalating consciousness regarding technologically progressive women’s health devices are navigating the market growth in the region.
Segments Covered in the Report
By Type
- Devices
- Consumables
By Product
- Surgical
- Diagnostics
- Contraceptives
- Labor & Delivery
- Critical Care
- Others
By Application
- Chronic Diseases
- General Health
- Reproductive Health
- Pelvic & Uterine Health
- Cancer
- Infectious Disease
- Uterine Fibroids
- Others
By End User
- Hospitals & Clinics
- Home Healthcare
- Obstetrics & Gynecology Clinics
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Others
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Market Scope
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- The report reviews the major players involved in the development of Women’s Health Devices and list all their pipeline projects
- Extensive coverage of the Women’s Health Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- Recent developments in the segment / industry
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Women’s Health Devices Market
5.1. COVID-19 Landscape: Women’s Health Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Women’s Health Devices Market, By Product
8.1. Women’s Health Devices Market, by Product Type, 2021-2030
8.1.1. Surgical
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Contraceptives
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Labor & Delivery
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Critical Care
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Women’s Health Devices Market, By Type
9.1. Women’s Health Devices Market, by Type, 2021-2030
9.1.1. Devices
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Consumables
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Women’s Health Devices Market, By Application Type
10.1. Women’s Health Devices Market, by Application Type, 2021-2030
10.1.1. Chronic Diseases
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. General Health
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Reproductive Health
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pelvic & Uterine Health
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Cancer
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Infectious Disease
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. Uterine Fibroids
10.1.7.1. Market Revenue and Forecast (2019-2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Women’s Health Devices Market, By End User Type
11.1. Women’s Health Devices Market, by End User Type, 2021-2030
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Home Healthcare
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Obstetrics & Gynecology Clinics
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Diagnostic Laboratories
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Ambulatory Surgical Centers
11.1.5.1. Market Revenue and Forecast (2019-2030)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Women’s Health Devices Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Type (2019-2030)
12.1.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Type (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Type (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Type (2019-2030)
12.2.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Type (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Type (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Type (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Type (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Type (2019-2030)
12.3.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Type (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Type (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Type (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Type (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Type (2019-2030)
12.4.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Type (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Type (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Type (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Type (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Type (2019-2030)
12.5.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Type (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Type (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Application Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)
Chapter 13. Company Profiles
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hologic
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Koninklijke Philips
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Prestige Consumer Healthcare, Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott Laboratories
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Caldera Medical
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. MedGyn Products
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medline Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Carestream Health
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global women’s health devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for women’s health devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1492
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
